About Standard
News
Products info
Research Development & Innovation
For Investors
Corporate Governance
Board of DiretorsShare Holder Meeting
Share Holder MeetingDividends
Dividends
About Standard
News
Products info
Research Development & Innovation
For Investors
Committed to advancing generics, Standard has been in the business for over 48 years and during that time has developed a deep understanding of the global market and the skills and experience needed to succeed in areas of sales, marketing, product development, clinical development, regulatory and medical affairs.
Standard has strong relationships with regulatory agencies enabling us to develop successful registration strategies in all major markets. The success of Standard has been built not only on developing a broad product portfolio but also in launching the difficult to do generics — taking on challenges of developing difficult APIs and formulations, products with difficult clinical and regulatory pathways, and patent challenges. Some of our successes have been achieved in collaboration with third parties.
Standard offers a cost effective alternative to potential partners who are interested in registering and commercializing their generic pharmaceuticals in Standard target markets.
Our interest in in-licensing varies depending on territory. We welcome you to submit your opportunity for our consideration.